Mesa Laboratories (MLAB) SVP exercises RSUs and sells 2,516 shares
Rhea-AI Filing Summary
Mesa Laboratories senior vice president of operations Brian David Archbold reported a mix of stock compensation activity and a modest sale of common shares. On June 18, 2026, he received a grant or award of 1,859 shares of common stock and exercised restricted stock units (RSUs) covering a total of 3,324 shares, converting them into common stock at a stated price of $95.10 per share for reporting purposes. Related RSU entries show derivative positions being fully converted into common stock.
On June 22, 2026, Archbold executed an open-market sale of 2,516 shares of Mesa Laboratories common stock at an average price of about $89.50 per share. After these transactions, he directly holds 6,377 common shares, indicating that a portion of the newly acquired stock was retained while some was sold for liquidity.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Archbold Brian David
Role
SVP Operations
Sold
2,516 shs ($225K)
Approx. gross sale proceeds
$225K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,516 | $89.502 | $225K |
| Exercise | Restricted Stock Units - 7 | 844 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units - 8 | 2,480 | $0.00 | $0.00 |
| Exercise | Common Stock | 844 | $95.10 | $80K |
| Exercise | Common Stock | 2,480 | $95.10 | $236K |
| Grant/Award | Common Stock | 1,859 | $95.10 | $177K |
Holdings After Transaction:
Restricted Stock Units - 7 — 0 shares (Direct);
Restricted Stock Units - 8 — 2,480 shares (Direct);
Common Stock — 6,377 shares (Direct)
Footnotes (5)
- F1. Each RSU represents a contingent right to receive one share of the Issuer's common stock
- F2. RSUs that vested June 21, 2024 and each of the next two anniversary dates
- F3. Not Applicable
- F4. RSUs that vest 1/3 on June 15, 2026 and each of the next 2 anniversary dates
- F5. Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY24-FY26 performance share unit program
Key Figures
Open-market sale: 2,516 shares at $89.5020
Post-sale holdings: 6,377 shares
Stock grant: 1,859 shares at $95.10
+3 more
6 metrics
Open-market sale
2,516 shares at $89.5020
Common Stock sale on June 22, 2026
Post-sale holdings
6,377 shares
Direct common stock held after June 22, 2026 sale
Stock grant
1,859 shares at $95.10
Grant/award acquisition on June 18, 2026
RSU exercises
3,324 shares at $95.10
Two derivative exercises into common stock on June 18, 2026
RSU series 8 exercised
2,480 RSUs
Converted into common stock; each RSU equals one share
RSU series 7 exercised
844 RSUs
Converted into common stock; remaining RSUs in this series now zero
Key Terms
Restricted Stock Units, performance share units, grant, award, or other acquisition, Exercise or conversion of derivative security, +1 more
5 terms
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant, award, or other acquisition financial
"Grant, award, or other acquisition"
Exercise or conversion of derivative security financial
"Exercise or conversion of derivative security"
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Mesa Laboratories (MLAB) report for Brian David Archbold?
Mesa Laboratories reported that SVP Operations Brian David Archbold received a stock grant, exercised restricted stock units into common shares, and sold 2,516 common shares in an open-market transaction, leaving him with 6,377 common shares held directly.
What stock awards did Brian David Archbold receive from Mesa Laboratories (MLAB)?
Brian David Archbold received an award of 1,859 shares of Mesa Laboratories common stock on June 18, 2026. The filing classifies this as a grant or award acquisition under transaction code A, increasing his direct holdings before subsequent transactions.
Did Brian David Archbold exercise restricted stock units in Mesa Laboratories (MLAB)?
Yes. The Form 4 shows he exercised RSU-derived positions labeled as Restricted Stock Units – 7 and – 8 into a total of 3,324 common shares. Each RSU represents a contingent right to receive one share of Mesa Laboratories common stock.